Showing results (401-410 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|September 30, 2010
Review article: eplerenone: an underused medication?Mohammad Abuannadi, James H O'KeefeJournal of Cardiovascular Pharmacology and Therapeutics|September 30, 2010
Effects of high- and low-sodium diets on ambulatory blood pressure in patients with hypertension receiving aliskirenMatthew R Weir, Anthony M Yadao, Das Purkayastha, et al.Journal of Cardiovascular Pharmacology and Therapeutics|November 25, 2010
A new agent for atrial fibrillation: electrophysiological properties of dronedaroneBramah N Singh, Eugenio CingolaniJournal of Cardiovascular Pharmacology and Therapeutics|November 25, 2010
A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submissionGerald V Naccarelli, Deborah L Wolbrette, Soraya Samii, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 14, 2010
Angiostatic effects of aspirin in hypoxia-reoxygenation are linked to modulation of TGFβ1 signalingMagomed Khaidakov, Jacob Szwedo, Sona Mitra, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 16, 2009
Lack of association of tegaserod with adverse cardiovascular outcomes in a matched case-control studyJeffrey L Anderson, Heidi T May, Tami L Bair, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 17, 2009
The effect of intracoronary nicorandil on coronary myocardial bridgingJae-Hun Jung, Pil-Ki Min, Chong Won Sung, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 18, 2010
Dronedarone therapy in atrial fibrillation: a summary of recent controlled trialsGabor Z Duray, Jörn Schmitt, Stefan H HohnloserJournal of Cardiovascular Pharmacology and Therapeutics|May 18, 2010
Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trialsUpdesh Singh Bedi, Mukesh Singh, Param Puneet Singh, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 21, 2010
Imipramine-induced cardiac depression is responsible for the increase in intracellular magnesium and the activation of ERK 1/2 in ratsMun-Young Lee, Shang-Jin Kim, Jin-Shang Kim, et al.Pageof 129